Clinical trial

Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study

NCT00176046 · Heidelberg University, Other · Completed

Key facts

NCT number NCT00176046
Title Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study
Official title Prospective Controlled Randomized Feasibility Study on a Treatment With Viscum Album in Patients With Breast Cancer to Identify Appropriate Surrogate Parameters for a Randomized Study of the Efficacy of Treatment With Mistletoe Extracts
Lead sponsor Heidelberg University, Other
Collaborators Verein für Krebsforschung, Arlesheim, Swizzerland Weleda AG, D-73525 Schwäbisch Gmünd
Status Completed
Phase Phase 4
Study type Interventional
Conditions Metastatic Breast Cancer
Intervention type Drug
Interventions viscum album pini
Enrollment 114
Start date May 1, 1999
Primary completion Jun 1, 2009
Completion Jul 1, 2009
First posted Sep 15, 2005
Last update posted May 8, 2017
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies